围术期度洛西汀用于腹腔镜子宫切除术后疼痛管理:一项随机安慰剂对照试验
该随机安慰剂对照试验在大学医院纳入80例因良性疾病行腹腔镜子宫切除术的患者,按1:1随机接受围术期度洛西汀(n=40)或安慰剂(n=40),术前2小时及术后24小时各给予60 mg两剂。结果显示两组QoR-40总分中位数分别为111/200和112/200,差异无统计学意义(p=.91),术后麻醉镇痛药使用及住院时间亦无差异(p>.05)。结论为围术期度洛西汀未减少腹腔镜子宫切除术后的疼痛、麻醉镇痛需求或住院时间。
要点
- 度洛西汀组与安慰剂组QoR-40总分中位数分别为111/200和112/200,差异无统计学意义(p=.91)。
- 恢复问卷各亚组分在两组间均未达统计学差异。
- 两组术后麻醉镇痛药使用及住院时间无差异(p>.05)。
核心结论
- 围术期度洛西汀未减少腹腔镜子宫切除术后的疼痛、麻醉镇痛需求或住院时间。
研究设计与样本
- 随机安慰剂对照试验,在大学医院开展,纳入100例患者后随机80例,按1:1分为度洛西汀组(n=40)和安慰剂组(n=40)。
- 患者因良性疾病于2017年11月至2018年3月行腹腔镜子宫切除术,术前2小时及术后24小时各接受60 mg度洛西汀或安慰剂两剂。
主要发现
- 度洛西汀组与安慰剂组QoR-40总分中位数分别为111/200和112/200,差异无统计学意义(p=.91)。
- 恢复问卷的身体独立性亚组分虽在数值上偏向度洛西汀,但各亚组分在两组间均未达统计学差异。
- 两组术后麻醉镇痛药使用及住院时间无差异(p>.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To evaluate the effect of perioperative duloxetine on pain management in patients recovering from laparoscopic hysterectomy. DESIGN: A randomized placebo-controlled trial. SETTING: A university hospital. PATIENTS: Of 100 patients enrolled, 80 were randomized 1:1 to receive perioperative duloxetine (n = 40) or placebo (n = 40). INTERVENTIONS: Patients undergoing laparoscopic hysterectomy for benign conditions from November 2017 through March 2018 received 2 doses of 60 mg duloxetine or placebo 2 hours before and 24 hours after surgery. MEASUREMENTS AND MAIN RESULTS: The Quality of Recovery (QoR)-40 questionnaire was completed by participants after discharge. Study and control groups were compared in terms of questionnaire scores, opioid analgesic use, and hospital length of stay. The baseline characteristics of the groups were comparable; median total QoR-40 scores were 111 of 200 and 112 of 200 for duloxetine and the placebo group, respectively; the difference did not reach statistical significance (p = .91). Although the physical independence subcomponent of the recovery questionnaire was improved in favor of duloxetine, none of the subcomponents reached statistical difference between groups. The groups did not differ in terms of postoperative narcotic analgesic use and hospital length of stay (p >.05). CONCLUSION: Perioperative duloxetine did not reduce pain, need for narcotic analgesia, or hospital length of stay following laparoscopic hysterectomy.
引用
- Takmaz O, Bastu E, Ozbasli E, et al. Perioperative Duloxetine for Pain Management After Laparoscopic Hysterectomy: A Randomized Placebo-Controlled Trial. J Minim Invasive Gynecol. 2019. PMID: 31476481. doi:10.1016/j.jmig.2019.04.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。